Decentralized Trial

MMS wins the Innovation Excellence Awards 2024

MMS has been honored with the prestigious Innovation Excellence Awards 2024 by CIO Bulletin, recognizing us as a Data-Centric CRO Powerhouse Reshaping Drug Development on a Global Scale.

MMS Wins Top Workplaces 2023 Award

Online Webinar

Type II Drug Master Files for Early-Stage, Small Molecule, Drug Development: Regulatory Management, Quality Considerations, and eCTD Submission

MMS Wins Top Workplaces 2023 Award

Good Work Comes From Great Places!

 global strategies for expedited regulatory approval

Press Release

MMS Supported MAPS Public Benefit Corporation NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD

Regulatory Submission

Sponsors Trust MMS With Their Submissions

Our integrated regulatory, writing, publishing, and QC teams have developed effective strategies and led data planning, summarization, and lifecycle management for 50+ marketing applications in the past 5 years.

Functional Service provider FSP

Modern FSP Solutions For An Evolving Industry

Our FSP models are designed to be flexible and scalable, bringing expertise that will increase levels of productivity to align with your organization’s goals.

THE DIFFERENCE IS IN THE DATA®

With strong science, robust processes, and a sense of urgency, MMS is redefining the CRO experience. Gain new insights from our data-focused and tech-enabled team of experts. Explore our services:

Regulatory Affairs & Operations

Regulatory Affairs
& Operations

Data Management & Biostatistics

Data Management
& Biostatistics

Regulatory & Medical Writing

Regulatory &
Medical Writing

Drug Safety and pharmacovigilance

Drug Safety &
Pharmacovigilance

Compliance & Transparency

Quality & Compliance 
Services

Transparency Services

Transparency
Services

MMS Light house

Helping sponsors navigate a complex regulatory environment

MMS is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards.

Industry experts across 4 continents are available to support your programs 24 hours a day with a 97 percent sponsor satisfaction rating

“This team never stopped working towards our deadline, and from day one, we were impressed with the efficient and smart decisions brought forth by MMS to bring this drug to market.” —Randy Brenner, Senior Vice President Global Regulatory Affairs, Quality, and Technical Operations, Paratek

“The choice in collaborating with MMS to meet this milestone… was simple, given their deep scientific knowledge and strategic resource models,” — Dr. Steven Gullans, CEO, Gemphire

Latest News

MAPS has submitted an NDA to the FDA for the first PTSD psychedelic therapy with MMS support

 MMS Named Great Place to Work in the UK as Growth in the Region DoublesDiscover the historic NDA submission by MAPS PBC for MDMA-assisted therapy in PTSD, with strategic support from MMS. Explore the potential breakthrough in psychedelic-assisted therapy for PTSD, advancing innovation in mental health treatments.

Latest Webinar

Type II Drug Master Files for Early-Stage, Small Molecule, Drug Development: Regulatory Management, Quality Considerations, & eCTD Submission

 Training That Transforms: A Quality ApproachThis webinar highlights the roadmap to efficiently navigate important aspects of Type II DMF management, quality components, and submission strategies that are essential for seamless filing and maintenance.

Featured Blog

The Silent Battle: Exploring PTSD Treatments and Psychedelic Research in Veteran Care

 EMA Revised Transparency Rules Eliminate the Deferral Mechanism for Clinical Trial Data PublicationDiscover a veteran’s journey with PTSD, exploring MMS’s role in psychedelic research. Learn about the VA’s support, FDA guidance, and efforts to improve mental health for veterans. Join the quest for breakthroughs.

Featured Sponsor

MMS Partners with I-ACT to Advance Children’s Clinical Trials

  Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS HoldingsMMS collaborates with I-ACT to accelerate pediatric clinical trials, supporting life-saving therapies for children. Learn more about the Spin Challenge and our commitment to advancing pediatric drug development.